Related Experiment Video
Updated: May 12, 2026
05:05
Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair
Published on: June 9, 2020
Recent advancements in tissue engineering for stem cell-based cardiac therapies
Alice Le Huu1, Arghya Paul, Liqin Xu
1Cardiothoracic Surgery & Surgical Research, Royal Victoria Hospital, Montreal, Quebec, Canada.
Therapeutic Delivery
|April 6, 2013
Summary
Stem cell therapy shows promise for cardiac repair, but poor cell survival and retention limit outcomes. Innovative tissue engineering and delivery systems are crucial for successful cellular cardiomyoplasty.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Biomedical Engineering
Background:
- Cardiac tissue engineering aims to regenerate damaged heart muscle after infarction.
- Stem cells offer potential for myocardial repair due to their regenerative capabilities.
- Clinical application of stem cells is hindered by issues like cell death and poor retention.
Purpose of the Study:
- To provide a comprehensive overview of stem cell technologies for myocardial repair.
- To explore advancements in tissue engineering for cellular cardiomyoplasty.
- To offer insights into the clinical realization of cellular cardiomyoplasty.
Main Methods:
- Review of recent advancements in stem cell technology for cardiac repair.
- Discussion of innovative tissue engineering techniques for cellular cardiomyoplasty.
- Analysis of multidisciplinary approaches to myocardial regeneration.
Main Results:
- Stem cell therapy is a key focus in cardiac tissue engineering.
- Efficient stem cell delivery systems are essential for improving clinical outcomes.
- Tissue engineering offers new possibilities for cellular cardiomyoplasty.
Conclusions:
- Advancements in stem cell technology and tissue engineering are vital for myocardial regeneration.
- Overcoming cell death and retention issues is critical for stem cell therapy success.
- A multidisciplinary approach is necessary for the clinical translation of cellular cardiomyoplasty.
